TECHNEUTRAL

TECH P/E Ratio Analysis

78.2x

Higher than 94% of Healthcare sector peers

Updated 29h ago·SEC filings & market data

Key Takeaway

The P/E ratio of 78.2x means investors are paying $78.20 for every $1.00 of current earnings, a valuation measure that shows how expensive the stock is relative to its profitability.

Sector Performance

94th percentile

TECH

78.2x

Sector Median

28.5x

Sector Avg

35.3x

Prior Period

106.8x(Apr 2026)

↑ Improving

📊

Deep Analysis

The P/E ratio of 78.2x means investors are paying $78.20 for every $1.00 of current earnings, a valuation measure that shows how expensive the stock is relative to its profitability.

This sits well above the healthcare sector median of 28.5x, placing Bio-Techne in the 94th percentile among sector peers, indicating a much higher valuation than most comparable companies. The trend data is N/A, with no year-over-year change or quarter-over-quarter change reported, so there is no available evidence of whether this multiple is expanding or contracting. The lack of trend information combined with a very high level means the valuation risk cannot be assessed directionally; it is simply an expensive stock with no clear momentum signal to justify or challenge that price. This metric does not contradict the overall NEUTRAL verdict, because the elevated P/E suggests limited margin of safety, but the absence of trend data prevents a more bearish or bullish conclusion.

Frequently Asked Questions

What does the P/E Ratio tell investors about TECH?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

How does TECH's P/E Ratio compare to its sector?

TECH's P/E Ratio of 78.2x compares to a Healthcare sector median of 28.5x, placing it in the 94th percentile.

Who are TECH's closest peers by P/E Ratio?

The closest Healthcare peers by P/E Ratio include: ABT (28.5x), CCLD (28.3x), ALGN (29.1x), AZN (27.0x), AMGN (24.7x).

📚

Learn More About P/E Ratio

DCF Valuation: How to Estimate What a Stock Is Actually Worth

Discounted Cash Flow is the most rigorous way to value a company. It's also the most misunderstood. Here's a plain-English walkthrough with a real example.

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.